[Clinical Talks] Genetic Testing for a Global Community
March 31, 2023 @ 09:00 – 09:30 CEST
Samuel Myllykangas, adjunct Professor at the Institute of Biomedicine, University of Helsinki, and co-founder of Blueprint Genetics. Samuel started his career by designing an entirely new method of sequencing the DNA (Oligonucleotide-Selective Sequencing) while working on his post-doctorate in the Stanford University. This method, published in Nature, sparked an idea of his own genetics company where he could apply his invention in the diagnostics of rare disease patients. Since then, Samuel has built an extensive experience in developing genomics technologies, bioinformatics tools and genetic testing solutions for rare diseases. Samuel runs Specialty Genetics at Quest Diagnostics and is the Managing Director of Blueprint Genetics. He is responsible for the overall success of the business, leading the development and execution of strategy and delivering on financial and operational targets.
Blueprint Genetics is a genetic testing company focused on inherited diseases. With a patient-first mindset, we deliver high-quality genetic testing to the global clinical community across 14 medical specialties. By combining a state-of-the-art laboratory process, the latest sequencing technology, AI empowered data-crunching tools and techniques, world-class professionals, and a holistic customer experience approach, we are bringing genetic knowledge to mainstream healthcare. Blueprint supports clinicians and their patients with comprehensive and high-quality tools and resources for diagnosis of genetic conditions. In doing so, we provide possibilities for targeted treatment and individualized care for patients.
Moderator: Päivi Östling, SciLifeLab
Clinical Talks is back for more! With a brand new and shiny Season 6. After successfully completing 5 seasons with > 70 enthusiastic Clinical Talkers to our record, we have barely scratched the surface of all the amazing work our clinical, academic and industry Life Science community has to offer. More about the upcoming events is available here.